Evaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic protein-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic protein

Published:2020-06-12 Issue:9 Volume:16 Page:2007-2017
ISSN:2164-5515
Container-title:Human Vaccines & Immunotherapeutics
language:en
Short-container-title:Human Vaccines & Immunotherapeutics

Author:

Torrey Heather L.¹^ORCID,Kaliaperumal Valarmathy¹,Bramhecha Yogesh¹^ORCID,Weir Genevieve M.¹^ORCID,Falsey Ann R.²,Walsh Edward E.²^ORCID,Langley Joanne M.³⁴^ORCID,Schepens Bert⁵⁶^ORCID,Saelens Xavier⁵⁶^ORCID,Stanford Marianne M.¹⁴^ORCID

Affiliation:

1. IMV Inc., Dartmouth, NS, Canada

2. University of Rochester, Rochester, NY, USA

3. Canadian Center for Vaccinology (IWK Health Centre and Nova Scotia Health Authority and Dalhousie University), Halifax, NS, Canada

4. Dalhousie University, Halifax, NS, Canada

5. VIB-UGent Center for Medical Biotechnology, Ghent, Belgium

6. Ghent University, Ghent, Belgium

Funder

IMV Inc

Publisher

Informa UK Limited

Subject

Pharmacology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/21645515.2020.1756671

Reference40 articles.

1. Respiratory syncytial virus infection in elderly adults

2. Respiratory syncytial virus infection in the late bone marrow transplant period: report of three cases and review

3. Bronchiolitis-Associated Hospitalizations Among US Children, 1980-1996

4. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study

5. Murine host responses to respiratory syncytial virus (RSV) following intranasal administration of a Protollin-adjuvanted, epitope-enhanced recombinant G protein vaccine

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Respiratory Syncytial Virus Vaccines: Analysis of Pre-Marketing Clinical Trials for Immunogenicity in the Population over 50 Years of Age;Vaccines;2024-03-25

2. All Eyes on the Prefusion-Stabilized F Construct, but Are We Missing the Potential of Alternative Targets for Respiratory Syncytial Virus Vaccine Design?;Vaccines;2024-01-18

3. RBF Protein with MA103 Adjuvant Elicited Protective Immunity against Human Respiratory Syncytial Virus in BALB/c Mice;Japanese Journal of Infectious Diseases;2023-05-31

4. Recent updates on correlates of vaccine-induced protection;Frontiers in Immunology;2023-01-27

5. Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape;The Lancet Infectious Diseases;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3